Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway.

Jin YL, Xin LM, Zhou CC, Ren Y

Open source

DOI
10.2147/ott.s180785
Published
2018
Container
OncoTargets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s180785,
  title = {Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway.},
  author = {Jin YL and Xin LM and Zhou CC and Ren Y},
  year = {2018},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s180785},
  url = {https://doi.org/10.2147/ott.s180785}
}

RIS

TY  - JOUR
TI  - Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway.
AU  - Jin YL
AU  - Xin LM
AU  - Zhou CC
AU  - Ren Y
PY  - 2018
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s180785
UR  - https://doi.org/10.2147/ott.s180785
ER  - 

APA

YL, J., LM, X., CC, Z., & Y, R. (2018). Polydatin exerts anti-tumor effects against renal cell carcinoma cells via induction of caspase-dependent apoptosis and inhibition of the PI3K/Akt pathway.. OncoTargets and therapy. https://doi.org/10.2147/ott.s180785

Source records